Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has accepted Intellipharmaceutics International’s Seroquel XR (quetiapine fumarate extended-release tablets) generic version’s abbreviated new drug application (ANDA).
Subscribe to our email newsletter
Seroquel XR is an oral psychotropic agent indicated for the treatment of schizophrenia, bipolar disorder and major depressive disorder.
Intellipharmaceutics CEO Isa Odidi said they were very pleased with the FDA’s acceptance of their filing for a generic of Seroquel extended-release capsules.